mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |